Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge

Virology

Volumn 258, Issue 2, 1999, Pages 208-216

  Ghiasi, Homayon ^a,b   Pemg, Guey Chuen ^a   Hofman, Florence M ^c   Cai, Steve ^a   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; IMMUNOSTIMULATION; LATENT PERIOD; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; TISSUE CULTURE; TRIGEMINUS GANGLION; VACCINATION; VIRUS INFECTION; VIRUS TRANSCRIPTION;

EID: 0033526528     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9710     Document Type: Article

References (38)

1. Ahmed R., King C. C., Oldstone M. B. Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo. J. Virol. 61:1987;1571-1576.
2. Autenrieth I. B., Hantschmann P., Heymer B., Heesemann J. Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: Evidence for the involvement of T lymphocytes. Immunobiology. 187:1993;1-16.
3. Blacklaws B. A., Nash A. A. Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice. J. Gen. Virol. 71:1990;863-871.
4. Buchmeier M. J., Welsh R. M., Dutko F. J., Oldstone M. B. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:1980;275-331.
5. Cook M. L., Bastone V. B., Stevens J. G. Evidence that neurons harbor latent herpes simplex virus. Infect. Immun. 9:1974;946-951.
6. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 66:1991;1051-1066.
7. Fraser N. W., Spivack J. G., Wroblewska Z., Block T., Deshmane S. L., Valyi-Nagy T., Natarajan R., Gesser R. M. A review of the molecular mechanism of HSV-1 latency. Curr. Eye Res. 10:1991;1-13.
8. Gesser R. M., Valyi-Nagy T., Fraser N. W., Altschuler S. M. Oral inoculation of SCID mice with an attenuated herpes simplex virus-1 strain causes persistent enteric nervous system infection and gastric ulcers without direct mucosal infection. Lab. Invest. 73:1995;880-889.
9. Ghiasi H., Cai S., Nesburn A. B., Wechsler S. L. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection. Virology. 224:1996;330-333.
10. Ghiasi H., Cai S., Nesburn A. B., Wechsler S. L. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1. Curr. Eye Res. 16:1997a;1152-1158.
11. Ghiasi H., Cai S., Slanina S., Nesburn A. B., Wechsler S. L. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Invest. Ophthalmol. Vis. Sci. 38:1997b;1213-1221.
12. Ghiasi H., Kaiwar R., Nesburn A. B., Slanina S., Wechsler S. L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): Comparative protection against lethal challenge in mice. J. Virol. 68:1994;2118-2126.
13. Ghiasi H., Roopenian D. C., Slanina S., Cai S., Nesburn A. B., Wechsler S. L. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Immunology. 91:1997c;430-435.
14. Grusby M. J., Auchincloss H. Jr., Lee R., Johnson R. S., Spencer J. P., Zijlstra M., Jaenisch R., Papaioannou V. E., Glimcher L. H. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl. Acad. Sci. USA. 90:1993;3913-3917.
15. Grusby M. J., Glimcher L. H. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13:1995;417-435.
16. Haywood A. M. Patterns of persistent viral infections. N. Engl. J. Med. 315:1986;939-948.
17. Jamieson B. D., Ahmed R. T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J. Exp. Med. 169:1989;1993-2005.
18. Jordan M. C., Jordan G. W., Stevens J. G., Miller G. Latent herpesviruses of humans. Ann. Intern. Med. 100:1984;866-880.
19. Karlhofer F. M., Yokoyama W. M. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. J. Immunol. 146:1991;3662-3673.
20. Kasai M., Iwamori M., Nagai Y., Okumura K., Tada T. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10:1980;175-180.
21. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 350:1991;423-426.
22. Koller B. H., Marrack P., Kappler J. W., Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science. 248:1990;1227-1230.
23. Koller B. H., Smithies O. Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. Natl. Acad. Sci. USA. 86:1989;8932-8935.
24. Lausch R. N., Staats H., Metcalf J. F., Oakes J. E. Effective antibody therapy in herpes simplex virus ocular infection. Characterization of recipient immune response. Intervirology. 31:1990;159-165.
25. Lynas C., Laycock K. A., Cook S. D., Hill T. J., Blyth W. A., Maitland N. J. Detection of herpes simplex virus type 1 gene expression in latently and productively infected mouse ganglia using the polymerase chain reaction. J. Gen. Virol. 70:1989;2345-2355.
26. Marion P. L., Robinson W. S. Hepadna viruses: Hepatitis B and related viruses. Curr. Top. Microbiol. Immunol. 105:1983;99-121.
27. McGeoch D. J., Dalrymple M. A., Davison A. J., Dolan A., Frame M. C., McNab D., Perry L. J., Scott J. E., Taylor P. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1988;1531-1574.
28. Perng G. C., Ghiasi H., Slanina S. M., Nesburn A. B., Wechsler S. L. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J. Virol. 70:1996a;976-984.
29. Perng G. C., Slanina S. M., Ghiasi H., Nesburn A. B., Wechsler S. L. A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J. Virol. 70:1996b;2014-2018.
30. Pinto A. J., Stewart D., van Rooijen N., Morahan P. S. Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphonate: Effects on antimicrobial resistance. J. Leukocyte Biol. 49:1991;579-586.
31. Preston C. M., Russell J., Harris R. A., Jamieson D. R. Herpes simplex virus latency in tissue culture cells. Gene Ther. 1:1994;S51.
32. Rock D. L., Nesburn A. B., Ghiasi H., Ong J., Lewis T. L., Lokensgard J. R., Wechsler S. L. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61:1987;3820-3826.
33. Stevens J. G. Persistent, chronic, and latent infections by herpesvirus: A review. IARC Sci. Publ. 24:1978;675-685.
34. Valyi-Nagy T., Deshmane S. L., Raengsakulrach B., Nicosia M., Gesser R. M., Wysocka M., Dillner A., Fraser N. W. Herpes simplex virus type 1 mutant strain in 1814 establishes a unique, slowly progressing infection in SCID mice. J. Virol. 66:1992;7336-7345.
35. Wechsler S. L., Nesburn A. B., Watson R., Slanina S., Ghiasi H. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J. Gen. Virol. 69:1988a;3101-3106.
36. Wechsler S. L., Nesburn A. B., Watson R., Slanina S. M., Ghiasi H. Fine mapping of the latency-related gene of herpes simplex virus type 1: Alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62:1988b;4051-4058.
37. Yoshimoto T., Bendelac A., Hu-Li J., Paul W. E. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA. 92:1995a;11931-11934.
38. Yoshimoto T., Bendelac A., Watson C., Hu-Li J., Paul W. E. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science. 270:1995b;1845-1847.